[go: up one dir, main page]

PL365000A1 - Agent for treating hepatitis c containing ukrain - Google Patents

Agent for treating hepatitis c containing ukrain

Info

Publication number
PL365000A1
PL365000A1 PL01365000A PL36500001A PL365000A1 PL 365000 A1 PL365000 A1 PL 365000A1 PL 01365000 A PL01365000 A PL 01365000A PL 36500001 A PL36500001 A PL 36500001A PL 365000 A1 PL365000 A1 PL 365000A1
Authority
PL
Poland
Prior art keywords
ukrain
agent
treating hepatitis
hepatitis
treating
Prior art date
Application number
PL01365000A
Other languages
Polish (pl)
Inventor
Wassyl Nowicky
Original Assignee
Wassyl Nowicky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wassyl Nowicky filed Critical Wassyl Nowicky
Publication of PL365000A1 publication Critical patent/PL365000A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL01365000A 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain PL365000A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (en) 2000-03-22 2000-03-22 AGENT FOR TREATING HEPATITIS C
PCT/AT2001/000076 WO2001070203A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Publications (1)

Publication Number Publication Date
PL365000A1 true PL365000A1 (en) 2004-12-27

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365000A PL365000A1 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Country Status (17)

Country Link
JP (1) JP2003527414A (en)
KR (1) KR20020087045A (en)
CN (1) CN1416347A (en)
AT (1) AT408719B (en)
AU (1) AU2001239000A1 (en)
BG (1) BG107088A (en)
BR (1) BR0107211A (en)
CA (1) CA2389173A1 (en)
EA (1) EA200200584A1 (en)
HR (1) HRP20020367A2 (en)
IL (1) IL149314A0 (en)
IS (1) IS6360A (en)
MA (1) MA25509A1 (en)
MX (1) MXPA02004993A (en)
NO (1) NO20022253L (en)
PL (1) PL365000A1 (en)
WO (1) WO2001070203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (en) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Process for reacting alkaloids.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2008039179A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (en) * 2015-07-13 2017-01-25 张如安 Beverage for killing hepatitis B virus
CN106109538A (en) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 The pharmaceutical composition for the treatment of hepatitis C

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (en) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "METHOD FOR DIAGNOSTICING AND FOR THE THERAPEUTIC TREATMENT OF TUMORS AND / OR INFECTIOUS DISEASES OF DIFFERENT TYPES WITH PREPARATIVE USE OF ALKALOID COMPOUNDS OR THEIR SALTS"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (en) * 1989-04-17 1991-01-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

Also Published As

Publication number Publication date
CA2389173A1 (en) 2001-09-27
NO20022253D0 (en) 2002-05-10
MA25509A1 (en) 2002-07-01
HRP20020367A2 (en) 2004-02-29
AU2001239000A1 (en) 2001-10-03
ATA4812000A (en) 2001-07-15
BR0107211A (en) 2004-01-06
CN1416347A (en) 2003-05-07
MXPA02004993A (en) 2003-10-14
EA200200584A1 (en) 2003-06-26
BG107088A (en) 2003-05-30
IS6360A (en) 2002-04-24
JP2003527414A (en) 2003-09-16
IL149314A0 (en) 2002-11-10
WO2001070203A2 (en) 2001-09-27
NO20022253L (en) 2002-05-10
WO2001070203A3 (en) 2002-09-06
KR20020087045A (en) 2002-11-21
AT408719B (en) 2002-02-25

Similar Documents

Publication Publication Date Title
EP1346724A4 (en) Remedies for hepatitis c
EP1429759A4 (en) Compounds useful for treating hepatitus c virus
HK1039947B (en) Hepatitis c inhibitor peptides
GB9821218D0 (en) Treatment for fabrics
GB0118884D0 (en) Apparatus for treating objects
GB9802022D0 (en) Complexing agents
AP2000001871A0 (en) Chemical agent for stabilizing soil
GB0118349D0 (en) Apparatus for treating objects
GB0118881D0 (en) Apparatus for treating objects
HK1042847A1 (en) Bone-pathobolism treating agent
AU2405002A (en) Dehalogeno compounds
PL365000A1 (en) Agent for treating hepatitis c containing ukrain
GB0121048D0 (en) Apparatus for treating objects
GB0118883D0 (en) Method for treating objects
GB0123897D0 (en) Method for treating objects
GB0122810D0 (en) Method for treating objects
GB9823835D0 (en) Component for vaccine
GB0007652D0 (en) Treatment for fabrics
AU138774S (en) Distiller
GB0007665D0 (en) Treatment for fabrics
GB0024364D0 (en) Method for treating stained materials
HU9900264V0 (en) Set for gas-treatment
PL332125A1 (en) Softeningh agent for textiles
HU9802686D0 (en) Process for guaranteed hair-restoration
GB9822887D0 (en) Hand garment for snowmobiles

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)